Blanket Purchase Agreement FA301618A0011
- Not listed
- This Blanket Purchase Agreement (BPA) was awarded by the Air Education and Training Command (AETC), a Defense agency, to Grifols Diagnostic Solutions Inc., a for-profit medical diagnostics company, to provide Procleix Panther Analyzer reagents in support of the Wilford Hall Ambulatory Surgical Center (WHASC) Armed Services Blood Donor Center San Antonio (ASBBC-SA) at Joint Base San Antonio-Lackland, Texas. The $10 million single-award BPA has a period of performance from October 1, 2024 to April...
- This Blanket Purchase Agreement was awarded to Grifols Diagnostic Solutions Inc. by the Air Education and Training Command, a Defense agency, on April 21, 2022, with a ceiling value of $10 million and a completion date of April 20, 2027. The contract is structured as a single-award, non-set-aside BPA established to supply Procleix Panther Analyzer reagents in support of the Wilford Hall Ambulatory Surgical Center Armed Services Blood Bank Center at Joint Base San Antonio Lackland, Texas. The BPA...
- This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit company, for the supply of blood bank reagents. The contract, valued at up to $36,593.10, has an ultimate completion date of May 31, 2022 and was awarded on June 1, 2020. The BPA was established under the VA's GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, Test Kits & Test Sets. Grifols, a global healthcare company, has...
- The Department of the Air Force Air Education and Training Command awarded a single-award Blanket Purchase Agreement (BPA) to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit organization, to provide Procleix Zika Assay reagent kits. The $840,000 BPA has a performance period through March 2024 and does not utilize any set-asides. Grifols is a global healthcare company that has received over $8 million in federal prime contracts to supply a range of critical medical laboratory...
- This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency, a defense agency, to Werfen USA LLC, a manufacturer of in vitro diagnostic equipment, reagents, and services. The $2,000,000 single-award BPA has a period of performance through October 3, 2029 and is for the procurement of testing supplies for transfusion services. Werfen, as the prime contractor, will provide specialized medical devices, consumables, and support services to the Defense Health Agency, Department...
- The Defense Health Agency (DHA) has awarded a $7.5 million Blanket Purchase Agreement (BPA) to One Lambda, Inc., a for-profit manufacturer of medical testing reagents and diagnostic kits. The BPA serves as a master ordering vehicle for laboratory supplies to support federal healthcare and research initiatives across multiple agencies, including the Department of Health and Human Services (HHS) National Institutes of Health (NIH), Department of Veterans Affairs (VA), and Department of Defense...
- This Blanket Purchase Agreement, awarded to Grandida, LLC on November 22, 2022, provides the Defense Health Agency with a flexible procurement mechanism for reagents and consumables with a ceiling value of $1.1 million through November 21, 2027. The single-award BPA, issued without a set-aside designation, leverages Grandida's established capability as a minority-owned, small disadvantaged business to supply laboratory and medical-grade reagents and related consumable materials to support the...
- This Blanket Purchase Agreement (BPA) was awarded by the Veterans Integrated Service Network 15 (VISN 15) of the U.S. Department of Veterans Affairs (VA) to Werfen USA LLC, a Massachusetts-based manufacturer of in vitro diagnostic equipment, reagents, and services. The $417,068.20 contract is for the delivery of blood bank reagents and was awarded under the General Services Administration's (GSA) Invitro Diagnostics, Reagents, Test (FSS-65-VII) schedule contract. The contract has a period of...
- The Blanket Purchase Agreement (BPA) identified by contract number HT001416A0087 was awarded by the Defense Health Agency (DHA), a defense agency, to Bio Rad Laboratories Inc., a large for-profit manufacturer of life science and clinical diagnostic products. The $6,500,000 single-award BPA, which does not have a small business set-aside, provides a streamlined procurement vehicle for the DHA to acquire a variety of specialized laboratory equipment, reagents, consumables, and maintenance services...
- This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency (DHA) to Becton, Dickinson and Company (BD) for the provision of diagnostic testing equipment, supplies, and reagents. The single-award BPA has a ceiling value of $7,000,000 and a period of performance extending through April 2030. As a prime contractor, BD will deliver a wide range of specialized medical diagnostic technologies and supporting services to the DHA, including blood culture systems, microbiology...
This Blanket Purchase Agreement (BPA) was awarded by the Air Education and Training Command, a defense agency, to Grifols Diagnostic Solutions Inc., a for-profit subsidiary of the global healthcare company Grifols. The $7,500,000 single-award BPA covers the provision of Procleix Reagents for Nucleic Acid Testing (NAT) for detecting Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and West Nile Virus (WNV). This specialized medical laboratory equipment and testing services support the diagnostic needs of federal healthcare networks, particularly within the Department of Veterans Affairs and Department of Defense medical systems. As a registered federal contractor, Grifols Diagnostic Solutions Inc. has established itself as a critical supplier of sophisticated medical laboratory technologies and has been awarded multiple Indefinite Delivery Vehicles (IDVs), including this BPA, which facilitates the ongoing procurement of its diagnostic products and services across various government healthcare institutions. The contract has a period of performance from June 1, 2018 to May 31, 2023.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 6/1/18 |